Haemodynamic mechanisms of corticotropin (ACTH)-induced hypertension in the rat

C Wen1, T Fraser, M Li

  • 1Department of Medicine, The St George Hospital, University of New South Wales, Sydney, Australia.

Journal of Hypertension
|February 5, 2000
PubMed

Insights

Corticotropin (ACTH)-induced hypertension in rats involves increased renal vascular resistance (RVR), not cardiac output or total peripheral resistance. Ramipril prevented both hypertension and increased RVR, suggesting RVR

Area of Science:

  • Cardiovascular Physiology
  • Renal Physiology
  • Endocrinology

Background:

  • Corticotropin (ACTH) is known to induce hypertension.
  • The precise mechanisms, including the roles of cardiac output and vascular resistances, in ACTH-induced hypertension remain incompletely understood.

Purpose of the Study:

  • To investigate the contribution of cardiac output (CO), systemic vascular resistance (SVR), and regional vascular resistances to ACTH-induced hypertension in a rat model.
  • To evaluate the effects of specific pharmacological interventions on these hemodynamic parameters during ACTH administration.

Main Methods:

  • Male Sprague-Dawley rats were treated with ACTH or saline (sham) for 10 days.
  • Groups received either atenolol (beta-blocker), minoxidil (vasodilator), or ramipril (ACE inhibitor) in combination with ACTH or sham treatment.
  • Hemodynamic parameters including blood pressure, cardiac output, and regional blood flows (renal, mesenteric, hindquarter) were measured.

Main Results:

  • ACTH treatment significantly increased blood pressure, cardiac output, and renal vascular resistance (RVR), but not total peripheral resistance (TPR).
  • Atenolol blocked the ACTH-induced rise in CO but did not affect the blood pressure increase.
  • Minoxidil reduced TPR but failed to prevent ACTH-induced hypertension or increased RVR. Ramipril attenuated both the rise in RVR and blood pressure.

Conclusions:

  • The development of ACTH-induced hypertension in rats is primarily associated with an increase in renal vascular resistance, rather than changes in cardiac output or total peripheral resistance.
  • Ramipril's ability to prevent both hypertension and increased RVR suggests a critical role for RVR in the pathogenesis of ACTH-induced hypertension.
Abstract

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Hypothalamic-Pituitary Axis01:37

Hypothalamic-Pituitary Axis

The response to stress—be it physical or psychological, acute or chronic—involves activation of the Hypothalamic-Pituitary-Adrenal (HPA) axis. The HPA axis is part of the neuroendocrine system because it involves both neuronal and hormonal communication. Its function is to regulate homeostatic systems—metabolic, cardiovascular, and immune—providing the necessary means to respond to a stressor.
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...